Glucocorticoid Receptor β (GRβ) : Beyond Its Dominant-Negative Function
Glucocorticoids (GCs) act via the GC receptor (GR), a receptor ubiquitously expressed in the body where it drives a broad spectrum of responses within distinct cell types and tissues, which vary in strength and specificity. The variability of GR-mediated cell responses is further extended by the existence of GR isoforms, such as GRα and GRβ, generated through alternative splicing mechanisms. While GRα is the classic receptor responsible for GC actions, GRβ has been implicated in the impairment of GRα-mediated activities. Interestingly, in contrast to the popular belief that GRβ actions are restricted to its dominant-negative effects on GRα-mediated responses, GRβ has been shown to have intrinsic activities and "directly" regulates a plethora of genes related to inflammatory process, cell communication, migration, and malignancy, each in a GRα-independent manner. Furthermore, GRβ has been associated with increased cell migration, growth, and reduced sensitivity to GC-induced apoptosis. We will summarize the current knowledge of GRβ-mediated responses, with a focus on the GRα-independent/intrinsic effects of GRβ and the associated non-canonical signaling pathways. Where appropriate, potential links to airway inflammatory diseases will be highlighted.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
International journal of molecular sciences - 22(2021), 7 vom: 31. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ramos-Ramírez, Patricia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 10.05.2021 Date Revised 10.05.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms22073649 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323629695 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323629695 | ||
003 | DE-627 | ||
005 | 20231225184607.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms22073649 |2 doi | |
028 | 5 | 2 | |a pubmed24n1078.xml |
035 | |a (DE-627)NLM323629695 | ||
035 | |a (NLM)33807481 | ||
035 | |a (PII)3649 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ramos-Ramírez, Patricia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Glucocorticoid Receptor β (GRβ) |b Beyond Its Dominant-Negative Function |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.05.2021 | ||
500 | |a Date Revised 10.05.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Glucocorticoids (GCs) act via the GC receptor (GR), a receptor ubiquitously expressed in the body where it drives a broad spectrum of responses within distinct cell types and tissues, which vary in strength and specificity. The variability of GR-mediated cell responses is further extended by the existence of GR isoforms, such as GRα and GRβ, generated through alternative splicing mechanisms. While GRα is the classic receptor responsible for GC actions, GRβ has been implicated in the impairment of GRα-mediated activities. Interestingly, in contrast to the popular belief that GRβ actions are restricted to its dominant-negative effects on GRα-mediated responses, GRβ has been shown to have intrinsic activities and "directly" regulates a plethora of genes related to inflammatory process, cell communication, migration, and malignancy, each in a GRα-independent manner. Furthermore, GRβ has been associated with increased cell migration, growth, and reduced sensitivity to GC-induced apoptosis. We will summarize the current knowledge of GRβ-mediated responses, with a focus on the GRα-independent/intrinsic effects of GRβ and the associated non-canonical signaling pathways. Where appropriate, potential links to airway inflammatory diseases will be highlighted | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a GR isoforms | |
650 | 4 | |a GRβ | |
650 | 4 | |a apoptosis | |
650 | 4 | |a glucocorticoids | |
650 | 4 | |a inflammation | |
650 | 4 | |a metabolism | |
650 | 4 | |a migration | |
650 | 4 | |a proliferation | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Protein Isoforms |2 NLM | |
650 | 7 | |a Receptors, Glucocorticoid |2 NLM | |
650 | 7 | |a glucocorticoid receptor alpha |2 NLM | |
650 | 7 | |a glucocorticoid receptor beta |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
700 | 1 | |a Tliba, Omar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 22(2021), 7 vom: 31. März |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:7 |g day:31 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms22073649 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 7 |b 31 |c 03 |